newsfilter
← Latest News
ACCESS Newswire·

Halberd Files Additional Extracorporeal Patent Application: Treatment of Covid-19 By Exposure to Tuned Radio Frequency Waves

JACKSON CENTER, PA / ACCESSWIRE / November 8, 2021 / Halberd Corporation (OTC:HALB) filed a non-provisional patent application for the extracorporeal treatment of Covid-19 through exposure to radio frequency waves. Previously, Halberd filed a provisional